Quebec SEAO #20155693

Transitional Procurement of Roche DNA Testing Kits for Prenatal Genomic Testing at CHU Sainte-Justine

CHU Sainte-Justine, a major healthcare institution in Quebec, is initiating a transitional procurement for DNA testing kits to support its Prenatal Genomic Test (TGPNI) program. - Government Buyer: - CHU Sainte-Justine (Centre hospitalier universitaire Sainte-Justine), Quebec - OEM Highlight: - Roche Diagnostics is the sole Original Equipment Manufacturer (OEM) specified - Vendors: - Roche Diagnostics (direct award) - Products/Services Requested: - KAPA HyperPrep DNA Testing Kit (Roche Diagnostics) - KAPA Pure Beads Reagent (Roche Diagnostics) - Both products are validated and have been used in mirror laboratories for seven years - No specific part numbers or quantities provided - Unique/Notable Requirements: - Direct award to Roche Diagnostics due to clinical validation and harmonization needs - Kits must be compatible with existing validated clinical methods; alternatives are not interchangeable - Procurement ensures continuity of service and avoids operational disruption until current kits reach obsolescence at the end of 2027 - Delivery required in Capitale-Nationale and Montréal regions - 18-month contract duration as a bridge until new solutions are available

Description

This procurement involves a transitional agreement with Roche Diagnostics for the supply of DNA testing kits used in prenatal genomic testing at CHU Sainte-Justine, Quebec. The transition is necessary due to upcoming obsolescence of current kits by December 31, 2027, and the need to maintain service stability until a planned future harmonized procurement process. The procurement aims to avoid operational disruption and ensure continuity of the prenatal genomic testing service, which relies on harmonized analytical methods and reagents between mirror laboratories. A direct award is requested as a transitional measure until the end of 2027 to avoid service disruption and ensure continuity.

View original listing